Investor082,
Nope, IFRs are not last resort they are first step for those seeking treatment of an approved but not yet reimbursed medicine under a NICE agreement. Hence a heavy load will shift to the five doctor panel considering IFR requests for treatment with murcidencel under a cancer, not GBM, designation on NHS’s high priced medicines list. No excuses by them and NHS for not being ready right?; ).
I know this seems to escape you but Doctors will do what their patients need done and that includes the paperwork needed for submitting an IFR. The funding for IFRs has increased significantly over the last year and because of the the broad nature of the indication on the high priced medicines list many types of cancer will be treated which is an obvious now to RWD from Specials. Go look up funding amounts shared on this board over the last year or so and feel free to share; ). Best wishes.
Market Data 
Markets 
AI
